mounjaro tirzepatide news today A new version of the diabetes drug can be used for weight loss, FDA says Tirzepatide (Mounjaro): Type 2 Diabetes
Description
Wright AK, Carr MJ, Kontopantelis E, Leelarathna L, Thabit H, Emsley R, et al
No specific outcome is promised
The trial escalation tables stepped the amount up on a monthly cadence, beginning in the low single-digit milligram range and only advancing once the prior level felt comfortable
the direction is not
News There may be a role for semaglutide, but GPs remain key in managing asthma in patients, says a respiratory expert
